Research Papers

25 of 284 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
45 years German Society of Biological Psychiatry (DGBP).
Riederer P; Kircher T; Juckel G; Domschke K; Schneider A; Deckert J; Falkai P.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity d…
Papp S; Tombor L; Kakuszi B; Réthelyi JM; Bitter I; Czobor P.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson's disease.
Tall P; Qamar MA; Batzu L; Leta V; Falup-Pecurariu C; Ray Chaudhuri K.
J Neural Transm (Vienna) (Unknown)
Published: 2023
1/6 Transparent
Apprends-moi l'art des petits pas: Levodopa, Carbidopa Intestinal Gel plus Entacapone.
Jost WH.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Blood neurofilament light chain in Parkinson's disease.
Buhmann C; Magnus T; Choe CU.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease.
Riederer P; Nagatsu T; Youdim MBH; Wulf M; Dijkstra JM; Sian-Huelsmann J.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson's disease and atypical Par…
Schröter N; van Eimeren T; Classen J; Levin J; Redecker C; Wolz M; Tönges L.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's d…
Leta V; van Wamelen DJ; Aureli F; Metta V; Trivedi D; Cortelli P; Rodriguez-Blazquez C; Rizos A; Ray Chaudhuri K.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tac…
Leßmann V; Kartalou GI; Endres T; Pawlitzki M; Gottmann K.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Data-driven subtyping of Parkinson's disease: comparison of current methodologies and application to the Bochum PNS coh…
Chen Q; Scherbaum R; Gold R; Pitarokoili K; Mosig A; Zella S; Tönges L.
J Neural Transm (Vienna) (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Ketogenic diet for mood disorders from animal models to clinical application.
Smolensky IV; Zajac-Bakri K; Gass P; Inta D.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Genetic testing for Parkinson's disease in clinical practice.
Gasser T.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Arm swing deviations in patients with Parkinson's disease at different gait velocities.
Mainka S; Lauermann M; Ebersbach G.
J Neural Transm (Vienna) (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Autism Spectrum Disorder and auditory sensory alterations: a systematic review on the integrity of cognitive and neuron…
Gonçalves AM; Monteiro P.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian …
Goto R; Kurihara M; Kameyama M; Komatsu H; Higashino M; Hatano K; Ihara R; Higashihara M; Nishina Y; Matsubara T; Kanemaru K; Saito Y; Murayama S; Iwata A.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease:…
Zagnoli F; Leblanc A; Viakhireva-Dovganyuk I; Delabrousse-Mayoux JP; Pouyet A; Ziegler M; Sogni L; Patat M; Bouillot R; Vérin M; APOKADO Group.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficit…
Bouter C; Ott FW; Günther D; Weig L; Schmitz-Peiffer F; Rozyyeva M; Beindorff N; Bouter Y.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome.
Grund KE; Zipfel A; Duckworth-Mothes B; Jost WH.
J Neural Transm (Vienna) (Unknown)
Published: 2023
1/6 Transparent
Neurological soft signs are increased in major depressive disorder irrespective of treatment.
Schülke R; Liepach K; Brömstrup AL; Folsche T; Deest M; Bleich S; Neyazi A; Frieling H; Maier HB.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine me…
Kozlova AA; Rubets E; Vareltzoglou MR; Jarzebska N; Ragavan VN; Chen Y; Martens-Lobenhoffer J; Bode-Böger SM; Gainetdinov RR; Rodionov RN; Bernhardt N.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.
Campagnolo M; Weis L; Fogliano C; Cianci V; Garon M; Fiorenzato E; Carecchio M; Ferreri F; Bisiacchi P; Antonini A; Biundo R.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Is abnormal metabolism in the olfactory bulb and amygdala associated with bipolar disorder?
Sancaktar M; Kocamer Şahin Ş; Demir B; Elboğa U; Elboğa G; Altındağ A.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The two-network framework of number processing: a step towards a better understanding of the neural origins of developm…
Klein E; Knops A.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder an…
Leplow B; Renftle D; Thomas M; Michaelis K; Solbrig S; Maetzler W; Berg D; Liepelt-Scarfone I.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The use of wearables for the diagnosis and treatment of Parkinson's disease.
Reichmann H; Klingelhoefer L; Bendig J.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared